Back
Corcept Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
78
CORT
Corcept Therapeutics
Last Price:
57.51
Seasonality Move:
2.29%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Corcept Therapeutics Stock Forecast
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 32.6% based on the past 20 years of stock performance.
- Corcept Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
-
Is Corcept Therapeutics Stock Undervalued?
The current Corcept Therapeutics [CORT] share price is $57.54. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal. - CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 32.6% based on the past 20 years of stock performance.
Corcept Therapeutics Stock Rating
Buy
78
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics overpriced?
- Corcept Therapeutics has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
Corcept Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
61.66
52-Week Low:
20.84
Prediction Charts
Market Cap:
6.03B
Price in USD:
57.54
Volume:
670.98K
Beta:
0.86
Technical Analysis
SMA50:
0.00
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
127.07%
Stock Predictions
-
Is Corcept Therapeutics stock public?
Yes, Corcept Therapeutics is a publicly traded company. -
What is the Corcept Therapeutics stock quote today?
The Corcept Therapeutics stock price is 57.54 USD today. -
How to buy Corcept Therapeutics stock online?
You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-5 | 50.00 | 52.14 | 52.35 | 49.51 |
| Nov-6 | 54.08 | 54.25 | 54.88 | 53.06 |
| Nov-7 | 54.11 | 54.30 | 55.24 | 53.65 |
| Nov-8 | 54.30 | 59.60 | 61.66 | 54.30 |
| Nov-11 | 59.88 | 59.12 | 60.05 | 58.02 |
| Nov-12 | 59.00 | 57.79 | 59.98 | 57.00 |
| Nov-13 | 58.02 | 56.43 | 59.26 | 56.43 |
| Nov-14 | 56.40 | 54.79 | 57.50 | 54.49 |
| Nov-15 | 55.09 | 51.83 | 55.22 | 51.51 |
| Nov-18 | 52.00 | 52.62 | 52.99 | 51.69 |
| Nov-19 | 52.79 | 54.31 | 54.57 | 52.25 |
| Nov-20 | 54.31 | 56.09 | 56.13 | 54.02 |
| Nov-21 | 56.16 | 55.92 | 57.24 | 55.34 |
| Nov-22 | 56.20 | 57.54 | 57.71 | 56.14 |
Corcept Therapeutics Earnings
Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics Forecast Revenue Growth
Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.